ATRC - AtriCure, Inc.

28.21
0.580   2.056%

Share volume: 646,897
Last Updated: 04-23-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$27.63
0.58
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
36%
Profitability 35%
Dept financing 29%
Liquidity 59%
Performance 32%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-2.01%
1 Month
-4.73%
3 Months
-26.75%
6 Months
-24.85%
1 Year
-16.41%
2 Year
22.39%
Key data
Stock price
$28.21
P/E Ratio 
0.00
DAY RANGE
$27.06 - $28.48
EPS 
-$0.24
52 WEEK RANGE
$27.06 - $43.18
52 WEEK CHANGE
-$15.54
MARKET CAP 
1.967 B
YIELD 
N/A
SHARES OUTSTANDING 
49.810 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-29-2025
BETA 
1.67
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$794,703
AVERAGE 30 VOLUME 
$655,852
Company detail
CEO: Michael H. Carrel
Region: US
Website: atricure.com
Employees: 1,050
IPO year: 2005
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue and systems, and intercostal nerves. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products. CryoICE Cryoablation System enables the user to make linear ablations of varied lengths. EPi-Sense Guided Coagulation System is used to treat persistent atrial fibrillation.

Recent news